NUCLEOTID SEQUENCE SET FOR MEDICAL TECHNOLOGY OF DETECTION OF DMD GENE DELETEIONS MOST PARTICULAR IN RUSSIA BY MULTIPLEX PCR/AFLP ANALYSIS Russian patent published in 2017 - IPC C12N1/00 

FIELD: biotechnology.

SUBSTANCE: set of nucleotide sequences that can be used to diagnose frequent deletions of the DMD gene responsible for Duchenne/Becker muscular dystrophy in the RF population, based on mutation frequencies among patients resident in the Russian Federation. Diagnosis of deletions affects the promoter region; 3, 4, 6, 8, 13, 17, 19, 32 42, 43, 44, 45, 47, 48, 50, 51, 52, 53, 60 exons of the DMD gene in the hemizygotic state.

EFFECT: improved efficiency of deletions diagnosing.

1 dwg